Trial · NCT03395080
Participant flow24
How many started, completed or left each group, period by period.
1 to 20 of 24
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | DKN-01 Monotherapy in Recurrent EEC | 29 | |
| Overall Study | STARTED | DKN-01+Paclitaxel in Recurrent EEC | 24 | |
| Overall Study | STARTED | DKN-01 Monotherapy in Recurrent EOC | 14 | |
| Overall Study | STARTED | DKN-01+Paclitaxel in Recurrent EOC | 19 | |
| Overall Study | STARTED | DKN-01 300mg Monotherapy in Carcinosarcoma | 1 | |
| Overall Study | STARTED | DKN-01 600mg Monotherapy in Carcinosarcoma | 8 | |
| Overall Study | STARTED | DKN-01 300mg + Paclitaxel in Carcinosarcoma | 4 | |
| Overall Study | STARTED | DKN-01 600 mg + Paclitaxel in Carcinosarcoma | 12 | |
| Overall Study | COMPLETED | DKN-01 Monotherapy in Recurrent EEC | 26 | |
| Overall Study | COMPLETED | DKN-01+Paclitaxel in Recurrent EEC | 21 | |
| Overall Study | COMPLETED | DKN-01 Monotherapy in Recurrent EOC | 13 | |
| Overall Study | COMPLETED | DKN-01+Paclitaxel in Recurrent EOC | 19 | |
| Overall Study | COMPLETED | DKN-01 300mg Monotherapy in Carcinosarcoma | 1 | |
| Overall Study | COMPLETED | DKN-01 600mg Monotherapy in Carcinosarcoma | 8 | |
| Overall Study | COMPLETED | DKN-01 300mg + Paclitaxel in Carcinosarcoma | 4 | |
| Overall Study | COMPLETED | DKN-01 600 mg + Paclitaxel in Carcinosarcoma | 10 | |
| Overall Study | NOT COMPLETED | DKN-01 Monotherapy in Recurrent EEC | 3 | |
| Overall Study | NOT COMPLETED | DKN-01+Paclitaxel in Recurrent EEC | 3 | |
| Overall Study | NOT COMPLETED | DKN-01 Monotherapy in Recurrent EOC | 1 | |
| Overall Study | NOT COMPLETED | DKN-01+Paclitaxel in Recurrent EOC | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03395080/flow